Correlation Between Blueprint Medicines and Atreca
Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and Atreca at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and Atreca into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blueprint Medicines Corp and Atreca Inc, you can compare the effects of market volatilities on Blueprint Medicines and Atreca and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of Atreca. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and Atreca.
Diversification Opportunities for Blueprint Medicines and Atreca
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Blueprint and Atreca is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and Atreca Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atreca Inc and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with Atreca. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atreca Inc has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and Atreca go up and down completely randomly.
Pair Corralation between Blueprint Medicines and Atreca
If you would invest 4,351 in Blueprint Medicines Corp on November 9, 2024 and sell it today you would earn a total of 6,611 from holding Blueprint Medicines Corp or generate 151.94% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Blueprint Medicines Corp vs. Atreca Inc
Performance |
| Timeline |
| Blueprint Medicines Corp |
| Atreca Inc |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Blueprint Medicines and Atreca Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Blueprint Medicines and Atreca
The main advantage of trading using opposite Blueprint Medicines and Atreca positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, Atreca can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atreca will offset losses from the drop in Atreca's long position.| Blueprint Medicines vs. Terns Pharmaceuticals | Blueprint Medicines vs. Amylyx Pharmaceuticals | Blueprint Medicines vs. Acumen Pharmaceuticals | Blueprint Medicines vs. Inozyme Pharma |
| Atreca vs. Passage Bio | Atreca vs. Stoke Therapeutics | Atreca vs. Revolution Medicines | Atreca vs. Black Diamond Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |